Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors,Acta Pharmaceutica Sinica B

当前位置： X-MOL 学术 › Acta Pharm. Sin. B › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors
Acta Pharmaceutica Sinica B ( IF 14.7 ) Pub Date : 2021-08-31 , DOI: 10.1016/j.apsb.2021.08.027
Shenghua Gao ₁ , Tianguang Huang ₁ , Letian Song ₁ , Shujing Xu ₁ , Yusen Cheng ₁ , Srinivasulu Cherukupalli ₁ , Dongwei Kang _{1,

2} , Tong Zhao ₁ , Lin Sun ₁ , Jian Zhang ₁ , Peng Zhan _{1,

2} , Xinyong Liu _{1,

2}

Affiliation

Novel therapies are urgently needed to improve global treatment of SARS-CoV-2 infection. Herein, we briefly provide a concise report on the medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors with representative examples in different strategies from the medicinal chemistry perspective.

中文翻译：